Systemic bacteraemia following haemorrhagic shock in mice: Alleviation with oral interleukin 6

Cytokine

Volumn 8, Issue 2, 1996, Pages 121-129

  Rollwagen, F M ^a   Li, Y Y ^b   Pacheco, N D ^a   Nielsen, T B ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

Author keywords

Cytokine; Haemorrhage; IL 6; Oral administration; Shock

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FLOW CYTOMETRY; HEMORRHAGIC SHOCK; MEAN ARTERIAL PRESSURE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE;

EID: 0030000461     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0017     Document Type: Article

References (32)

1. Cue JI, Peyton JC, Malangoni MA (1992) Does blood transfusion or hemorrhagic shock induce immunosuppression? J Trauma 32:613-617.
2. Esrig BC, Frazee L, Stephenson SF, Polk HC Jr., Fulton RL, Jones CE (1977) The predisposition to infection following hemorrhagic shock. Surg Gynecol Obstet 144:915-917.
3. Ertel, W, Morrison MH, Ayala A, Dean RE, Chaudry IH (1992) Interferon-gamma attenuates hemorrhage-induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis. Surgery 111:177-187.
4. Oka Y, Murata A, Nishijima J, Yasuda T, Hiraoka N, Ohmachi Y, Kitagawa K, Yasuda T, Toda H, Tanaka N, Mori T (1992) Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 4:298-304.
5. Baker JW, Deitch EA, Li M, Berg RD, Specian RD (1988) Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 28:896-904.
6. Deitch EA (1990) Bacterial translocation of the gut flora. J Trauma 30:S184-S189.
7. Bark T, Katouli M, Ljungqvist O, Mollby R, Svenberg T (1993) Bacterial translocation after non-lethal hemorrhage in the rat. Circ Shock 41:60-65.
8. Livingston DH, and Malangoni MA (1988) Interferon-γ restores immune competence after hemorrhagic shock. J Surg Res 45:37-43.
9. Abraham E, Freitas AA (1989) Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J Immunol 142:899-906.
10. Stephan RN, Ayala A, Harkema JM, Dean RE, Border JR, Chaudry IH (1989) Mechanism of immunosuppression following hemorrhage: defective antigen presentation by macrophages. J Surg Res. 46:553-556.
11. Zapata-Sirvent RL, Hansbrough JF, Cox MC, Carter WH (1992) Immunologic alterations in a murine model of hemorrhagic shock. Crit Care Med 20:508-517.
12. Ayala A, Perrin MM, Wang P, Ertel W, Chaudry IH (1991) Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen. J Immunol 147:4147-4154.
13. Baqar S, Pacheco ND, Rollwagen FM (1993) Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob Agents Chemother 37:2688-2692.
14. Rollwagen FM, Stutman O (1981) Culture generated suppressors: evidence for an adherent cell component. Cell Immunol 64:371-380.
15. Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC, Jr. (1993) Lymphocyte subset responses to trauma and sepsis. J Trauma 35:844-849.
16. Maeda Y, Matsumoto M, Hori O, Kuwabara K, Ogawa S, Yan SD, Ohtsuki T, Kinoshita T, Kamada T, Stern DM (1994) Hypoxia/reoxygenation-mediated induction of astrocyte interleukin-6: a paracrine mechanism potentially enhancing neuron survival. J Exp Med 180:2297-2308.
17. Hancock WW, Khoury SJ, Carpenter CB, Sayegh MH (1994) Differential effects of oral versus intrathymic administration of polymorphic major histocompatibility complex class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. Am J Pathol 144:1149-1158.
18. Koren S, Fleischmann WR, Jr. (1993) Orally administered interferons suppress bone marrow function. Proc Soc Expt Biol Med 204:155-164.
19. Rollwagen, FM, Pacheco ND, Li Y-Y, Auerbach R, Sneed R, Nielsen TB (1993) Cell surface antigen expression in a murine endothelioma cell line in response to cytokines. J Cell Biochem 17A:335 (Abstr).
20. Darville T, Tabor DR, Theus SA, Jacobs RF (1992) Surface matrix binding alters murine peritoneal mononuclear phagocyte TNF-a and IL-6 induction. Immunol Invest 21:539-552.
21. McGee DW, Beagley KW, Aicher WK, McGhee, JR (1993) Transforming growth factor-beta and IL-1 beta act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 151:970-978.
22. Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH (1990) Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2:170-174.
23. Feder LS, Laskin DL (1994) Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1β following acute endotoxemia. J Leuk Biol 55:507-513.
24. Zhu X, Ayala A, Zellweger R, Morrison MH, Chaudry IH (1994) Peritoneal macrophages show increased cytokine gene expression following haemorrhagic shock. Immunol 83:378-383.
25. Deitch EA, Xu D, Franko L, Ayala A, Chaudry IH (1994) Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock. 1:141-146.
26. Rollwagen FM, Gafney WCM, Pacheco ND, Davis TA, Hickey TN, Nielsen TB, Rudolph AS (1995) Multiple responses to administration of liposome encapsulated hemoglobin (LEH): effects on hematopoiesis and serum IL-6 levels. Exp Hematol in press.
27. Ohkawa F, Ikeda U, Kawasaki K, Kusano E, Igarashi M, Shimada K (1994) Inhibitory effect of interleukin-6 on vascular smooth muscle contraction. Am J Physiol 266:H898-H902.
28. Tatsuno, I, Somogyvarivigh A, Mizuno K, Gottschall PE, Hidaka H, Arimura A (1991) Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide. Endocrinology 129:1797-1804.
29. Cummins JM, Tompkins MB, Olsen RG, Tompkins WA, Lewis MG (1988) Oral use of human alpha interferon in cats. J Biol Response Mod 7:513-523.
30. Rollwagen FM, Pacheco ND, Clements JD, Pavlovskis O, Rollins DM, Walker RI (1993) Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant. Vaccine 11:1316-1320.
31. Watson J (1979) Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J Exp Med 150:1510-1519.
32. SAS User's Guide: Statistics version 5 (1985) SAS Institute, Gary NC.